Focused Protein degradation is currently being explored as an alternative strategy in cancer, whereby the normal protein degradation method is co-opted for therapeutic applications. Lately made novel molecules identified as proteolysis-concentrating on chimeras (PROTACs) are heterobifunctional molecules with two ligands joined by a linker. A person ligand binds to the https://www.directivepublications.org/journal-of-clinical-breast-cancer/